SYNCOMF vs SHUKRAPHAR: Stock Comparison

Head-to-head financial and trading comparison between Syncom Formulations (India) Limited (SYNCOMF) and Shukra Pharmaceuticals Limited (SHUKRAPHAR) in the Cross-Sector Peers sector.

SYNCOMF

NSE: SYNCOMF
Syncom Formulations (India) Limited
₹23.28
1Y Return: +71.3%
52W High: ₹26.18
52W Low: ₹12.94
Annual Volatility: 87.57%
Check SYNCOMF Trade Fees →

SHUKRAPHAR

NSE: SHUKRAPHAR
Shukra Pharmaceuticals Limited
₹66.94
1Y Return: +61.61%
52W High: ₹72.58
52W Low: ₹41.42
Annual Volatility: 64.68%
Check SHUKRAPHAR Trade Fees →

Key Metrics Comparison Table

MetricSYNCOMFSHUKRAPHAREdge / Winner
Current Market Price (CMP) ₹23.28 ₹66.94 —
1-Year Price Return +71.3% +61.61% SYNCOMF (9.69% higher)
52-Week High ₹26.18 ₹72.58 —
52-Week Low ₹12.94 ₹41.42 —
30-Day Annualized Volatility 87.57% 64.68% SHUKRAPHAR (Steadier)
30-Day Average Daily Volume 28,558,317 6,592,919 SYNCOMF (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between SYNCOMF and SHUKRAPHAR, which stock gave better returns over the last year?

SYNCOMF has outperformed SHUKRAPHAR over the past 12 months with a gain of 71.3% compared to 61.61%.

Which stock is less volatile: SYNCOMF or SHUKRAPHAR?

SHUKRAPHAR demonstrated lower price volatility (64.68% annualized) compared to SYNCOMF (87.57%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of SYNCOMF vs SHUKRAPHAR?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are SYNCOMF and SHUKRAPHAR direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.